gavreto - pralsetinib capsule
(Pralsetinib)Genentech, Inc.
Usage: GAVRETO is a kinase inhibitor for adults with metastatic RET fusion-positive non-small cell lung cancer, and for adults and patients 12+ with advanced or metastatic RET fusion-positive thyroid cancer requiring systemic therapy who are radioactive iodine-refractory.